Australia flagARTG 376512

LASSOSTAR™ Circular Mapping Catheter - Electrophysiology cardiac catheter, single-use

ARTG ID: 376512 · Johnson & Johnson Medical Pty Ltd · Biosense Webster Inc · Class III · Started October 18, 2021

Good Name: Johnson & Johnson Medical Pty Ltd - LASSOSTAR™ Circular Mapping Catheter - Electrophysiology cardiac catheter, single-use

Device classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration information
ARTG ID
376512
Start Date
October 18, 2021
Effective Date
October 18, 2021
Sponsor
Manufacturer
Country
United States of America
Address
31 Technology Drive Suite 200, Irvine, California, 92618
Intended purpose

Indicated for multiple electrode electrophysiological recording and stimulation of the atrial region of the heart. When used in conjunction with a radiofrequency (RF) ablation catheter and a compatible multi-channel generator, the catheter can be used to facilitate ablation of cardiac arrhythmias.

About this record

Access comprehensive regulatory information for LASSOSTAR™ Circular Mapping Catheter - Electrophysiology cardiac catheter, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 376512 and sponsored by Johnson & Johnson Medical Pty Ltd, manufactured by Biosense Webster Inc in United States of America. The device registration started on October 18, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free DatabasePowered by Pure Global AITGA ARTG Official Data